LEADER 04035nam 2200517 450 001 9910737271803321 005 20230820032550.0 010 $a90-04-52613-7 035 $a(CKB)5720000000176913 035 $a(MiAaPQ)EBC30592290 035 $a(Au-PeEL)EBL30592290 035 $a(EXLCZ)995720000000176913 100 $a20230820d2023 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGoverning, protecting, and regulating the future of genome editing $ethe significance of ELSPI perspectives /$fedited by Santa Slokenberga, Timo Minssen, and Ana Nordberg 205 $a1st ed. 210 1$aLeiden, The Netherlands :$cBrill/Nijhoff,$d[2023] 210 4$dİ2023 215 $a1 online resource 300 $aIncludes index. 311 $a90-04-52608-0 327 $aGenome editing : learning from its past and envisioning its future / Judit Sandor -- Transformation of medical care through gene therapy and human rights to life and health -balancing risks and benefits / Anne Kjersti Befring -- Somatic genome editing with the use of AI : big promises but doubled legal issues / Anastasiya Kiseleva -- Addressing cognitive vulnerabilities through genome and epigenome editing : techno-legal adaptations for persons with intellectual disabilities / Pin Lean Lau -- Regulating heritable human genome editing : drawing the line between legitimate and controversial use / Noemi Conditi -- The European Court of Human Rights and the emergence of human germline genome editing-'The right to life' and 'the right to (artificial) procreation' / Merel M. Spaander -- The object-based and process-based regulation of genome editing / Michal Kos?c?i?k and Elis?ka Vladi?kova? -- A room with a view (and with a gene therapy drug) : gene therapy medicinal products and genetic tourism in Europe / Vera Lucia Raposo -- What would it take to enable germline editing in Europe for medical purposes? / Santa Slokenberga -- Genetics and justice, non-ideal theory and the role of patents : the case of CRISPR-Cas9 / Oliver Feeney -- Balancing innovation, 'Ordre Public' and morality in human germline editing : a call for more nuanced approaches in patent law / Duncan Matthews, Timo Minssen, and Ana Nordberg -- The application of EU competition law to the exploitation of human genome editing technology / Vladimir Bastidas Venegas. 330 $a"This edited collection examines the ethical, legal, social and policy implications of genome editing technologies. Moreover, it offers a broad spectrum of timely legal analysis related to bringing genome editing to the market and making it available to patients, including addressing genome editing technology regulation through procedures for regulatory approval, patent law and competition law. In twelve chapters, this volume offers persuasive arguments for justifying transformative regulatory interventions regarding human genome editing, as well as the various legal venues for introducing necessary or desirable changes needed to create an environment for realizing the potential of genome editing technology for the benefit of patients and society"--$cProvided by publisher. 606 $aGene therapy$xLaw and legislation 606 $aGenetic engineering$xLaw and legislation 606 $aHuman genetics$xLaw and legislation 606 $aGene editing$xTechnological innovations 615 0$aGene therapy$xLaw and legislation. 615 0$aGenetic engineering$xLaw and legislation. 615 0$aHuman genetics$xLaw and legislation. 615 0$aGene editing$xTechnological innovations. 676 $a344.04196 702 $aSlokenberga$b Santa$f1987- 702 $aMinssen$b Timo 702 $aNordberg$b Ana 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910737271803321 996 $aGoverning, protecting, and regulating the future of genome editing$93554395 997 $aUNINA